Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-27 @ 11:03 PM
Study NCT ID:
NCT00967993
Status:
COMPLETED
Last Update Posted:
2014-12-05
First Post:
2009-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Sponsor:
Keryx Biopharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-27
First Submit QC Date:
None
Study First Post Date:
2009-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-04
Results First Submit QC Date:
None
Results First Post Date:
2014-11-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-19
Last Update Post Date:
2014-12-05
Last Update Post Date Type:
ESTIMATED